A Study to Evaluate the Dosing, Effectiveness and Safety of Topiramate for the Treatment of Epilepsy

Clinical trial NCT00266604 · COMPLETED

Trial details

NCT number: NCT00266604
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Epilepsy Seizures Epilepsies, Partial Epilepsy, Generalized Seizures, Tonic-Clonic

Start date: 2005-12-01
Enrollment: 409

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.